Skip to Main Content

Advertisement

Skip Nav Destination

Abstract B121: Phase I study of MK‐0646, a humanized monoclonal antibody against IGF‐1R in combination with gemcitabine or gemcitabine + erlotinib (E) for advanced previously untreated pancreatic cancer

Mol Cancer Ther (2009) 8 (12_Supplement): B121.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Giorgio V. Scagliotti
  • Silvia Novello
Cancer Treatment Reviews (2012) 38 (4): 292.
  • Yasushi Goto
  • Ikuo Sekine
  • Maki Tanioka
  • Takashi Shibata
  • Chiharu Tanai
  • Hajime Asahina
  • Hiroshi Nokihara
  • Noboru Yamamoto
  • Hideo Kunitoh
  • Yuichiro Ohe
  • Hironori Kikkawa
  • Emiko Ohki
  • Tomohide Tamura
Investigational New Drugs (2012) 30 (4): 1548.
Close Modal

or Create an Account

Close Modal
Close Modal